SNI-2011 治疗干燥综合征患者-猫眼课题宝

SNI-2011 治疗干燥综合征患者

批准号：

6281714

负责人：

ALAN W FRIEDMAN

金额：

$1.36万

依托单位：

UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON

依托单位国家：

美国

项目类别：

财政年份：

1997

资助国家：

美国

项目状态：

已结题

起止时间：

1997-12-01 至 1998-11-30

来源：

https://reporter.nih.gov/project-details/6281714

关键词：

Sjogren's syndrome cholinergic agents clinical research human subject human therapy evaluation immunopathology chemotherapy

中文摘要

翻译

点击翻译按钮获取中文摘要

英文摘要

Sjogren's syndrome is an immunological disorder characterized by dry eyes and dry mouth, which includes diminished or absent secretion of glandular tissue. SNI-2011, a quinuclidine derivative of acetylcholine, is a muscarinic agonist associated with improved glandular ability to increase salivation and lacrimation. This study will compare the efficacy of two doses of SNI-2011 (15 mg and 30 mg tid) with placebo on the patients' subjective global evaluation of dryness (mouth, eyes, and overall).

期刊论文(0)

专著(0)

科研奖励(0)

会议论文